世界のアルビニズム用医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Albinism Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5072
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、アルビニズム用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（感光性医薬品、ホルモン剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・アルビニズム用医薬品の市場動向
・企業の競争状況、市場シェア
・アルビニズム用医薬品の種類別市場規模と予測2016-2027（感光性医薬品、ホルモン剤、その他）
・アルビニズム用医薬品の用途別市場規模と予測2016-2027（病院、診療所、その他）
・アルビニズム用医薬品の北米市場規模2016-2027（アメリカ、カナダ）
・アルビニズム用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・アルビニズム用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・アルビニズム用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル）
・アルビニズム用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bayer、Johnson & Johnson Services、CENTOGENE、HumanOptics、AVITA Medical、Merck、LABORATOIRES GENEVRIER、AbbVie、CELGENE、GlaxoSmithKline、Allergan、Clinuvel Pharmaceuticals）
・結論

Albinism is a rare group of genetic disorders that cause the skin, hair, or eyes to have little or no color.

Market Analysis and Insights: Global Albinism Drug Market
The global Albinism Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Albinism Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Albinism Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Albinism Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Albinism Drug market.

Global Albinism Drug Scope and Market Size
Albinism Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Albinism Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Photosensitive Drugs
Hormone Drugs
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Johnson & Johnson Services
CENTOGENE
HumanOptics
AVITA Medical
Merck
LABORATOIRES GENEVRIER
AbbVie
CELGENE
GlaxoSmithKline
Allergan
Clinuvel Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Albinism Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Photosensitive Drugs
1.2.3 Hormone Drugs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Albinism Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Albinism Drug Market Perspective (2016-2027)
2.2 Albinism Drug Growth Trends by Regions
2.2.1 Albinism Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Albinism Drug Historic Market Share by Regions (2016-2021)
2.2.3 Albinism Drug Forecasted Market Size by Regions (2022-2027)
2.3 Albinism Drug Industry Dynamic
2.3.1 Albinism Drug Market Trends
2.3.2 Albinism Drug Market Drivers
2.3.3 Albinism Drug Market Challenges
2.3.4 Albinism Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Albinism Drug Players by Revenue
3.1.1 Global Top Albinism Drug Players by Revenue (2016-2021)
3.1.2 Global Albinism Drug Revenue Market Share by Players (2016-2021)
3.2 Global Albinism Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Albinism Drug Revenue
3.4 Global Albinism Drug Market Concentration Ratio
3.4.1 Global Albinism Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Albinism Drug Revenue in 2020
3.5 Albinism Drug Key Players Head office and Area Served
3.6 Key Players Albinism Drug Product Solution and Service
3.7 Date of Enter into Albinism Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Albinism Drug Breakdown Data by Type
4.1 Global Albinism Drug Historic Market Size by Type (2016-2021)
4.2 Global Albinism Drug Forecasted Market Size by Type (2022-2027)

5 Albinism Drug Breakdown Data by Application
5.1 Global Albinism Drug Historic Market Size by Application (2016-2021)
5.2 Global Albinism Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Albinism Drug Market Size (2016-2027)
6.2 North America Albinism Drug Market Size by Type
6.2.1 North America Albinism Drug Market Size by Type (2016-2021)
6.2.2 North America Albinism Drug Market Size by Type (2022-2027)
6.2.3 North America Albinism Drug Market Size by Type (2016-2027)
6.3 North America Albinism Drug Market Size by Application
6.3.1 North America Albinism Drug Market Size by Application (2016-2021)
6.3.2 North America Albinism Drug Market Size by Application (2022-2027)
6.3.3 North America Albinism Drug Market Size by Application (2016-2027)
6.4 North America Albinism Drug Market Size by Country
6.4.1 North America Albinism Drug Market Size by Country (2016-2021)
6.4.2 North America Albinism Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Albinism Drug Market Size (2016-2027)
7.2 Europe Albinism Drug Market Size by Type
7.2.1 Europe Albinism Drug Market Size by Type (2016-2021)
7.2.2 Europe Albinism Drug Market Size by Type (2022-2027)
7.2.3 Europe Albinism Drug Market Size by Type (2016-2027)
7.3 Europe Albinism Drug Market Size by Application
7.3.1 Europe Albinism Drug Market Size by Application (2016-2021)
7.3.2 Europe Albinism Drug Market Size by Application (2022-2027)
7.3.3 Europe Albinism Drug Market Size by Application (2016-2027)
7.4 Europe Albinism Drug Market Size by Country
7.4.1 Europe Albinism Drug Market Size by Country (2016-2021)
7.4.2 Europe Albinism Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Albinism Drug Market Size (2016-2027)
8.2 Asia-Pacific Albinism Drug Market Size by Type
8.2.1 Asia-Pacific Albinism Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Albinism Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Albinism Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Albinism Drug Market Size by Application
8.3.1 Asia-Pacific Albinism Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Albinism Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Albinism Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Albinism Drug Market Size by Region
8.4.1 Asia-Pacific Albinism Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Albinism Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Albinism Drug Market Size (2016-2027)
9.2 Latin America Albinism Drug Market Size by Type
9.2.1 Latin America Albinism Drug Market Size by Type (2016-2021)
9.2.2 Latin America Albinism Drug Market Size by Type (2022-2027)
9.2.3 Latin America Albinism Drug Market Size by Type (2016-2027)
9.3 Latin America Albinism Drug Market Size by Application
9.3.1 Latin America Albinism Drug Market Size by Application (2016-2021)
9.3.2 Latin America Albinism Drug Market Size by Application (2022-2027)
9.3.3 Latin America Albinism Drug Market Size by Application (2016-2027)
9.4 Latin America Albinism Drug Market Size by Country
9.4.1 Latin America Albinism Drug Market Size by Country (2016-2021)
9.4.2 Latin America Albinism Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Albinism Drug Market Size (2016-2027)
10.2 Middle East & Africa Albinism Drug Market Size by Type
10.2.1 Middle East & Africa Albinism Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Albinism Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Albinism Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Albinism Drug Market Size by Application
10.3.1 Middle East & Africa Albinism Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Albinism Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Albinism Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Albinism Drug Market Size by Country
10.4.1 Middle East & Africa Albinism Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Albinism Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Albinism Drug Introduction
11.1.4 Bayer Revenue in Albinism Drug Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Johnson & Johnson Services
11.2.1 Johnson & Johnson Services Company Details
11.2.2 Johnson & Johnson Services Business Overview
11.2.3 Johnson & Johnson Services Albinism Drug Introduction
11.2.4 Johnson & Johnson Services Revenue in Albinism Drug Business (2016-2021)
11.2.5 Johnson & Johnson Services Recent Development
11.3 CENTOGENE
11.3.1 CENTOGENE Company Details
11.3.2 CENTOGENE Business Overview
11.3.3 CENTOGENE Albinism Drug Introduction
11.3.4 CENTOGENE Revenue in Albinism Drug Business (2016-2021)
11.3.5 CENTOGENE Recent Development
11.4 HumanOptics
11.4.1 HumanOptics Company Details
11.4.2 HumanOptics Business Overview
11.4.3 HumanOptics Albinism Drug Introduction
11.4.4 HumanOptics Revenue in Albinism Drug Business (2016-2021)
11.4.5 HumanOptics Recent Development
11.5 AVITA Medical
11.5.1 AVITA Medical Company Details
11.5.2 AVITA Medical Business Overview
11.5.3 AVITA Medical Albinism Drug Introduction
11.5.4 AVITA Medical Revenue in Albinism Drug Business (2016-2021)
11.5.5 AVITA Medical Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Albinism Drug Introduction
11.6.4 Merck Revenue in Albinism Drug Business (2016-2021)
11.6.5 Merck Recent Development
11.7 LABORATOIRES GENEVRIER
11.7.1 LABORATOIRES GENEVRIER Company Details
11.7.2 LABORATOIRES GENEVRIER Business Overview
11.7.3 LABORATOIRES GENEVRIER Albinism Drug Introduction
11.7.4 LABORATOIRES GENEVRIER Revenue in Albinism Drug Business (2016-2021)
11.7.5 LABORATOIRES GENEVRIER Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Albinism Drug Introduction
11.8.4 AbbVie Revenue in Albinism Drug Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 CELGENE
11.9.1 CELGENE Company Details
11.9.2 CELGENE Business Overview
11.9.3 CELGENE Albinism Drug Introduction
11.9.4 CELGENE Revenue in Albinism Drug Business (2016-2021)
11.9.5 CELGENE Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Albinism Drug Introduction
11.10.4 GlaxoSmithKline Revenue in Albinism Drug Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development
11.11 Allergan
11.11.1 Allergan Company Details
11.11.2 Allergan Business Overview
11.11.3 Allergan Albinism Drug Introduction
11.11.4 Allergan Revenue in Albinism Drug Business (2016-2021)
11.11.5 Allergan Recent Development
11.12 Clinuvel Pharmaceuticals
11.12.1 Clinuvel Pharmaceuticals Company Details
11.12.2 Clinuvel Pharmaceuticals Business Overview
11.12.3 Clinuvel Pharmaceuticals Albinism Drug Introduction
11.12.4 Clinuvel Pharmaceuticals Revenue in Albinism Drug Business (2016-2021)
11.12.5 Clinuvel Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Albinism Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Photosensitive Drugs
Table 3. Key Players of Hormone Drugs
Table 4. Key Players of Other
Table 5. Global Albinism Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Albinism Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Albinism Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Albinism Drug Market Share by Regions (2016-2021)
Table 9. Global Albinism Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Albinism Drug Market Share by Regions (2022-2027)
Table 11. Albinism Drug Market Trends
Table 12. Albinism Drug Market Drivers
Table 13. Albinism Drug Market Challenges
Table 14. Albinism Drug Market Restraints
Table 15. Global Albinism Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Albinism Drug Market Share by Players (2016-2021)
Table 17. Global Top Albinism Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Albinism Drug as of 2020)
Table 18. Ranking of Global Top Albinism Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Albinism Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Albinism Drug Product Solution and Service
Table 22. Date of Enter into Albinism Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Albinism Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Albinism Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Albinism Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Albinism Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Albinism Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Albinism Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Albinism Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Albinism Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Albinism Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Albinism Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Albinism Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Albinism Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Albinism Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Albinism Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Albinism Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Albinism Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Albinism Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Albinism Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Albinism Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Albinism Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Albinism Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Albinism Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Albinism Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Albinism Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Albinism Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Albinism Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Albinism Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Albinism Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Albinism Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Albinism Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Albinism Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Albinism Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Albinism Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Albinism Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Albinism Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Albinism Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Albinism Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Albinism Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Albinism Drug Product
Table 65. Bayer Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Johnson & Johnson Services Company Details
Table 68. Johnson & Johnson Services Business Overview
Table 69. Johnson & Johnson Services Albinism Drug Product
Table 70. Johnson & Johnson Services Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 71. Johnson & Johnson Services Recent Development
Table 72. CENTOGENE Company Details
Table 73. CENTOGENE Business Overview
Table 74. CENTOGENE Albinism Drug Product
Table 75. CENTOGENE Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 76. CENTOGENE Recent Development
Table 77. HumanOptics Company Details
Table 78. HumanOptics Business Overview
Table 79. HumanOptics Albinism Drug Product
Table 80. HumanOptics Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 81. HumanOptics Recent Development
Table 82. AVITA Medical Company Details
Table 83. AVITA Medical Business Overview
Table 84. AVITA Medical Albinism Drug Product
Table 85. AVITA Medical Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 86. AVITA Medical Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Albinism Drug Product
Table 90. Merck Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 91. Merck Recent Development
Table 92. LABORATOIRES GENEVRIER Company Details
Table 93. LABORATOIRES GENEVRIER Business Overview
Table 94. LABORATOIRES GENEVRIER Albinism Drug Product
Table 95. LABORATOIRES GENEVRIER Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 96. LABORATOIRES GENEVRIER Recent Development
Table 97. AbbVie Company Details
Table 98. AbbVie Business Overview
Table 99. AbbVie Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 100. AbbVie Recent Development
Table 101. CELGENE Company Details
Table 102. CELGENE Business Overview
Table 103. CELGENE Albinism Drug Product
Table 104. CELGENE Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 105. CELGENE Recent Development
Table 106. GlaxoSmithKline Company Details
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Albinism Drug Product
Table 109. GlaxoSmithKline Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 110. GlaxoSmithKline Recent Development
Table 111. Allergan Company Details
Table 112. Allergan Business Overview
Table 113. Allergan Albinism Drug Product
Table 114. Allergan Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 115. Allergan Recent Development
Table 116. Clinuvel Pharmaceuticals Company Details
Table 117. Clinuvel Pharmaceuticals Business Overview
Table 118. Clinuvel Pharmaceuticals Albinism Drug Product
Table 119. Clinuvel Pharmaceuticals Revenue in Albinism Drug Business (2016-2021) & (US$ Million)
Table 120. Clinuvel Pharmaceuticals Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Albinism Drug Market Share by Type: 2020 VS 2027
Figure 2. Photosensitive Drugs Features
Figure 3. Hormone Drugs Features
Figure 4. Other Features
Figure 5. Global Albinism Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Albinism Drug Report Years Considered
Figure 10. Global Albinism Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Albinism Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Albinism Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Albinism Drug Market Share by Regions (2022-2027)
Figure 14. Global Albinism Drug Market Share by Players in 2020
Figure 15. Global Top Albinism Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Albinism Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Albinism Drug Revenue in 2020
Figure 17. Global Albinism Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Albinism Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Albinism Drug Market Share by Type (2016-2027)
Figure 21. North America Albinism Drug Market Share by Application (2016-2027)
Figure 22. North America Albinism Drug Market Share by Country (2016-2027)
Figure 23. United States Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Albinism Drug Market Share by Type (2016-2027)
Figure 27. Europe Albinism Drug Market Share by Application (2016-2027)
Figure 28. Europe Albinism Drug Market Share by Country (2016-2027)
Figure 29. Germany Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Albinism Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Albinism Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Albinism Drug Market Share by Region (2016-2027)
Figure 39. China Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Albinism Drug Market Share by Type (2016-2027)
Figure 47. Latin America Albinism Drug Market Share by Application (2016-2027)
Figure 48. Latin America Albinism Drug Market Share by Country (2016-2027)
Figure 49. Mexico Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Albinism Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Albinism Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Albinism Drug Market Share by Country (2016-2027)
Figure 55. Turkey Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Albinism Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bayer Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 59. Johnson & Johnson Services Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 60. CENTOGENE Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 61. HumanOptics Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 62. AVITA Medical Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 64. LABORATOIRES GENEVRIER Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 65. AbbVie Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 66. CELGENE Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 68. Allergan Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 69. Clinuvel Pharmaceuticals Revenue Growth Rate in Albinism Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年）

Global Hypothyroidism Drug Market Size, Status and Forecast 2021-2027
QFJ1-4342 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、甲状腺機能低下症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）、用途別市場規模（病院、診療所、その他）、主要地域...

世界の抗コリン薬市場規模・現状・予測（2021年-2027年）

Global Anticholinergic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5583 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗コリン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口、局所）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界のデシタビン薬市場規模・現状・予測（2021年-2027年）

Global Decitabine Drug Market Size, Status and Forecast 2021-2027
QFJ1-5691 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、デシタビン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダコゲン、ジェネリック）、用途別市場規模（病院、ドラックストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年）

Global Acute Hepatic Porphyria Drug Market Size, Status and Forecast 2021-2027
QFJ1-5564 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、急性肝性ポルフィリン症用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（350 Mg、313 Mg）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメ...

世界のシクロベンザプリン医薬品市場規模・現状・予測（2021年-2027年）

Global Cyclobenzaprine Drug Market Size, Status and Forecast 2021-2027
QFJ1-5687 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、シクロベンザプリン医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、カプセル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の成長ホルモン用医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Growth Hormone Drug Market The global Growth Hormone Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypothyroidism Drug Market The global Hypothyroidism Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
世界の腸内細菌科感染症治療薬市場規模・現状・予測（2021年-2027年） Enterobacteriaceae infections are caused by Enterobacter species, pathogens responsible for causing severe infections including bacteremia, urinary tract infections, lower respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections. Market Analysis and Insights: Glo…